03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Atropine Sulfate Aguettant 0.5mg/5ml : | |
Type | Medicine Authorised |
Originator | G |
Agent | Pharmamed |
Distributor | Pharmamed |
Laboratory | Aguettant |
Responsible Party | Aguettant |
Origin | France |
Manufacturer | Aguettant |
Manufacturing Type | G |
Origin | France |
ATC | A03BA01 |
Atropine Sulfate Aguettant 0.5mg/5ml :
Atropine Sulfate Aguettant 0.5mg/5ml :
Atropine Sulfate Aguettant 0.5mg/5ml :
Atropine Sulfate Aguettant 0.5mg/5ml :
Atropine Sulfate Aguettant 0.5mg/5ml :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Atropine Sulfate Aguettant 0.5mg/5ml :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Accommodation disorder | Very Common |
Agitation | Not known |
Allergic reaction | Rare |
Anaphylaxis | Very rare |
Angina pectoris | Very rare |
Anhidrosis | Very Common |
Arrhythmia | Common |
Ataxia | Not known |
Atrial arrhythmia | Very rare |
Convulsive disorder | Rare |
Coordination disturbance | Common |
Decreased bronchial secretion | Very Common |
Dry mouth (Xerostomia) | Very Common |
Excitement | Common |
Flushing | Common |
Hallucination | Common |
Headache dull | Not known |
Hypertension | Very rare |
Hyperthermia | Common |
Insomnia | Not known |
Mental confusion | Common |
Mydriasis (dilated pupils) (Dilatation pupillary) | Very Common |
Photophobia | Very Common |
Psychotic reactions | Uncommon |
Skin Eruption | Very Common |
Somnolence | Rare |
Tachycardia | Common |
Thirst | Very Common |
Urinary retention | Common |
Urticaria | Very Common |
Ventricular fibrillation | Very rare |
Vision blurred | Very Common |
Atropine Sulfate Aguettant 0.5mg/5ml :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Atropine Sulfate Aguettant 0.5mg/5ml MoH 11027 :
Form | Solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 10x5ml |
Strength | 0.5mg/5ml |
Public Price | 7805375.55 L.L. |
Stratum | C |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 83421/1 |
Submission date | 23/06/2021 |
Registration Year | 04/04/2022 |
Price Comparison
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 10x5ml | |
● Public Price: | 7805375.55 LBP | ( 7,805,375.55 LBP ) |
● Pack size unit used: | 10 | |
● Cost/Unit: | 780537,56 LBP | ( 780,537.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File